These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Monitoring and managing graft health in the kidney transplant recipient. Josephson MA Clin J Am Soc Nephrol; 2011 Jul; 6(7):1774-80. PubMed ID: 21734093 [TBL] [Abstract][Full Text] [Related]
30. Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Dienemann T; Fujii N; Li Y; Govani S; Kosaraju N; Bloom RD; Feldman HI Transpl Int; 2016 Sep; 29(9):1017-28. PubMed ID: 27284760 [TBL] [Abstract][Full Text] [Related]
31. Recommendations for outpatient monitoring of kidney transplant recipients. Hariharan S Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S22-36. PubMed ID: 16567238 [TBL] [Abstract][Full Text] [Related]
32. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP; Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789 [TBL] [Abstract][Full Text] [Related]
33. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA Clin Transpl; 2006; ():57-70. PubMed ID: 18368705 [TBL] [Abstract][Full Text] [Related]
34. General health management and long-term care of the renal transplant recipient. Cohen D; Galbraith C Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S10-24. PubMed ID: 11729002 [TBL] [Abstract][Full Text] [Related]
35. Kidney transplantation: evaluation and clinical outcome of 237 recipients at low, medium, high, or strong immunological risk of rejection. Nascimento E; Fabreti de Oliveira RA; Maciel MD; Pereira AB; das Mercêz de Lucas F; Salomão-Filho A; Pereira WA; Moreira JB; Vilaça SS; de Castro Gontijo R; Lasmar MF; Vianna HR; Magalhâes A; Calazans CA; Simão-Filho C; Vilela B Transplant Proc; 2014; 46(1):101-7. PubMed ID: 24507033 [TBL] [Abstract][Full Text] [Related]
36. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up. Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200 [TBL] [Abstract][Full Text] [Related]
37. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient. Kutzler HL; Ye X; Rochon C; Martin ST Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
39. Living-related small bowel transplant: management of rejection and infection. Fujimoto Y; Uemoto S; Inomata Y; Kurokawa T; Koshiba T; Takatsuki M; Hino H; Tanaka K Transplant Proc; 1998 Feb; 30(1):149. PubMed ID: 9474986 [No Abstract] [Full Text] [Related]